Spark Investment Management LLC Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Spark Investment Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 12, 2020	SELL	$29.01 - $74.23 $342,318 - $875,914	-11,800 Closed	0 $0
Q1 2020 May 12, 2020	SELL	$27.51 - $57.29 $2.48 Million - $5.16 Million	-90,100 Reduced 88.42%	11,800 $401,000
Q4 2019 Feb 11, 2020	SELL	$40.86 - $57.65 $429,030 - $605,325	-10,500 Reduced 9.34%	101,900 $5.55 Million
Q3 2019 Nov 12, 2019	SELL	$37.38 - $49.47 $2.06 Million - $2.73 Million	-55,200 Reduced 32.94%	112,400 $4.69 Million
Q2 2019 Aug 12, 2019	BUY	$39.79 - $67.01 $497,375 - $837,625	12,500 Added 8.06%	167,600 $7.34 Million
Q1 2019 May 07, 2019	BUY	$34.52 - $53.29 $4.06 Million - $6.26 Million	117,500 Added 312.5%	155,100 $7.98 Million
Q4 2018 Feb 12, 2019	BUY	$29.75 - $42.9 $1.12 Million - $1.61 Million	37,600 New	37,600 $1.39 Million

792K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.18B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of Spark Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Spark Investment Management LLC with notifications on news.